Mogamulizumab-kpkc (MOAs, administration, toxicity) and its FDA-approval is discussed followed by (9:00) updates lenvatinib (a good update) and azithromycin (a bad update) in cancer patients.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
